RHUMBLINE ADVISERS

Position in FTRE — Fortrea Holdings Inc.

CIK 1115418 BOSTON, MA

Position in FTRE

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,384,191

+$2,147,243 QoQ

Shares Held

251,965

+6.1% QoQ

Ownership

0.265%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#52

of 334 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 52% Shared 0% None 48%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. FTRE ranks #59 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,384,191	251,965	+6.1%	Shares	Sole	2026-08-12
2026-03-31	$2,236,948	237,468	+2.1%	Shares	Sole	2026-05-12
2025-12-31	$4,012,194	232,591	-20.7%	Shares	Sole	2026-02-13
2025-09-30	$2,470,251	293,379	-2.9%	Shares	Sole	2025-11-06
2025-06-30	$1,491,993	302,023	+28.2%	Shares	Sole	2025-08-12
2025-03-31	$1,779,165	235,651	+0.5%	Shares	Sole	2025-05-29
2024-12-31	$4,374,152	234,539	+1.8%	Shares	Sole	2025-05-29
2024-09-30	$4,609,500	230,475	-0.1%	Shares	Sole	2024-11-12
2024-06-30	$5,386,942	230,803	-3.2%	Shares	Sole	2024-08-01
2024-03-31	$9,571,222	238,446	-5.5%	Shares	Sole	2024-05-09
2023-12-31	$8,806,700	252,341	+0.2%	Shares	Sole	2024-02-08
2023-09-30	$7,196,560	251,716	—	Shares	Sole	2023-11-09
No filing history on record for this holder in this stock.